📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
40
Warrant Exposure
90
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
49%
📜 Warrant Exercise
60%
• Massive warrant overhang: 75% of shares outstanding
• Warrant risk score very high (90/100)
📉 Score Deterioration
40%
• Score rose 31 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($22M, 43% of market cap)
• Active ATM program with $3M remaining capacity
💹 Market Data
Market Cap$51.75M
Shares Outstanding21.29M
Float15.37M
Cash$2.46M
Debt$8.75M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 22.8% shares (2025Q4 vs prior)
38 institutional holders · 3.40M shares
#1
CORSAIR CAPITAL MANAGEMENT, L.P.
768.6K shares
#2
VANGUARD GROUP INC
645.5K shares
#3
Corient Private Wealth LLC
476.2K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest520.1K
Days to Cover3.8
% of Float3.4%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2025
xbrl
XBRL CONVERTIBLE
Sep 30, 2020
8-K
8K EVENT
May 01, 2026
4
INSIDER TRANSACTION
Apr 28, 2026
4
INSIDER TRANSACTION
Apr 28, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CNVS
📊 CNVS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CNVS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.